A stock purchase by U.S. Senator John Boozman is drawing renewed attention to how members of Congress trade shares of companies whose fortunes are tied directly to federal contracts. Boozman's first reported purchase of Palantir Technologies (NASDAQ: PLTR), made on May 15, 2026, in a disclosed range of $1,001 to $15,000, has gained roughly 28.4% since, far outpacing the S&P 500's approximately 4.6% return over the same stretch.
Palantir shares traded near $134 when Boozman bought in; they closed around $172 at the time the trade drew scrutiny, after dipping below $110 and recovering through the mid-$120s before their recent surge. The purchase itself wasn't disclosed until June 16, 2026, roughly a month after it was executed, within the reporting window Congress members are allowed under existing disclosure rules.
A senator with a view into defense spending
What has made the trade notable isn't its size, which is modest by Washington standards, but Boozman's position on the Senate Appropriations Committee and its Defense Subcommittee — panels with direct visibility into the federal budgets that fund exactly the kind of contracts Palantir depends on. Palantir has built its business around data analytics and AI platforms sold to defense and intelligence agencies, making it one of the largest U.S. government software contractors. Political figures with financial stakes tied to companies they help oversee has become a recurring flashpoint in Washington, and Palantir's dependence on federal budgets makes it a frequent test case.
There is no evidence of wrongdoing or that Boozman acted on non-public information — insider trading laws still apply to lawmakers regardless of committee assignment. But critics argue that even fully disclosed, legal trades in a company this exposed to a lawmaker's own committee jurisdiction can create the appearance of a conflict of interest, since the optics of a defense appropriator profiting from a defense contractor are hard to separate from the underlying financial relationship.
Related: Trump Media Scraps CRO Treasury and Prediction Market Deals With Crypto.com
Part of a broader pattern
Boozman is far from the only member of Congress trading Palantir stock. Lawmakers have collectively disclosed 45 PLTR trades over the past six months across several members, with nine trades in that window split between four purchases and five sales. Representative Jonathan Jackson's December 2025 Palantir purchase, made while he sat on the House Foreign Affairs Committee, drew similar criticism for the same underlying reason: national-security-adjacent committee members trading stock in companies whose revenue depends on national-security-adjacent contracts.
The numbers behind the run-up
Palantir's stock move isn't disconnected from its underlying business performance. The company posted second-quarter 2026 revenue of roughly $1.94 billion, a 93% year-over-year increase, driven in part by U.S. commercial revenue that jumped 149% to $764 million and government revenue that grew about 90%. Palantir has guided full-year 2026 revenue to between $8.15 billion and $8.16 billion, implying roughly 82% annual growth, while maintaining adjusted free cash flow margins above 60% and a debt-free balance sheet. That combination of fundamentals helps explain the stock's momentum independent of any single lawmaker's trade — but it doesn't resolve the underlying tension between congressional oversight and personal portfolios that stories like Boozman's keep surfacing.
